QUESTIONS FOR THE VYADERM PHARMACEUTICALS CASE$($A$)$ Using data

from case exhibit $8$ calculate the following:$1)2017$ EVA for the

North American Dermatology Division$2)2017$ EVA bonus payout for a

manager assuming that the manager$$s salary is $$300,000$ and the

bonus is based $100\%$ on divisional EVA$3)2018$ EVA and estimated

bonus payout for the same manager, assuming that Vyaderm profits

fall back to historical levels and that the EVA improvement goal

remains constant.$($B$)$ Based on your analysis what would you

recommend to Mr$.$ Vedrine?